Germack相关文献与解析，生知库 | 链接生命科学的每一步

Leary, Peter J; Le, Rachel J; Panjabi, Sumeet; Hartney, John; Goyal, Amit; Ward, Charlotte; Mukherjee, Dwaipayan; Hatton, Nathan; Rayner, Samuel G; Germack, Hayley D; Ryan, John J

肺动脉高压

心血管

发表日期：2025

文献求助收藏

Impact of treatment escalation on rehospitalization among patients with pulmonary arterial hypertension

治疗升级对肺动脉高压患者再入院的影响

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-90975-4

Mazurek, Jeremy A; Germack, Hayley D; Gauthier-Loiselle, Marjolaine; Satija, Ambika; Manceur, Ameur M; Shi, Sherry; Cloutier, Martin; Lefebvre, Patrick; Panjabi, Sumeet

Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015-2019)

接受吸入三联疗法治疗的慢性阻塞性肺疾病急性加重患者的特征和结局：美国 SIRIUS I 队列研究结果（2015-2019 年）

期刊:International Journal of Chronic Obstructive Pulmonary Disease

影响因子:3.1

doi:10.2147/COPD.S513573

Nordon, Clementine; Carstens, Donna; Fagerås, Malin; Müllerová, Hana; Veeranki, Phani S; Alves, João André; Germack, Hayley D; Barnes, Timothy L; McCormack, Meredith C

慢性阻塞性肺疾病

发表日期：2025

文献求助收藏

Variation in Prevalence and Burden of Chronic Obstructive Pulmonary Disease by State and Insurance Type in the United States

美国各州和不同保险类型慢性阻塞性肺疾病患病率和疾病负担的差异

期刊:Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation

影响因子:2

doi:10.15326/jcopdf.2024.0560

Bazell, Carol; Alston, Maggie; Feigler, Norbert; Germack, Hayley D; Leary, Stephanie; Fopalan, Winston; Mannino, David

慢性阻塞性肺疾病

发表日期：2025

文献求助收藏

Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States

美国肺动脉高压治疗中断的相关因素

期刊:Pulmonary Circulation

影响因子:2.5

doi:10.1002/pul2.12326

Farber, Harrison W; Germack, Hayley D; Croteau, Nicole S; Simeone, Jason C; Tang, Fei; Paoli, Carly J; Doad, Gurinderpal; Panjabi, Sumeet; De Marco, Teresa

Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)

肺动脉高压（PAH）患者延迟诊断的经济负担

期刊:Pharmacoeconomics-Open

影响因子:2.1

doi:10.1007/s41669-023-00453-8

DuBrock, Hilary M; Germack, Hayley D; Gauthier-Loiselle, Marjolaine; Linder, Jörg; Satija, Ambika; Manceur, Ameur M; Cloutier, Martin; Lefebvre, Patrick; Panjabi, Sumeet; Frantz, Robert P

US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies

美国商业健康保险计划在肺动脉高压治疗方面的覆盖动态

期刊:

影响因子:

doi:10.18553/jmcp.2024.30.6.541

Rucker, Julia A; Beinfeld, Molly T; Enright, Daniel E; Germack, Hayley D; Panjabi, Sumeet; Chakinala, Murali M; Chambers, James D

Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis

美国结缔组织疾病相关肺动脉高压患者的真实世界治疗模式：一项基于索赔数据的回顾性分析

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-023-02658-z

Sargent, Therese; Tsang, Yuen; Panjabi, Sumeet; Funtanilla, Vienica; Germack, Hayley D; Gauthier-Loiselle, Marjolaine; Manceur, Ameur M; Cloutier, Martin; Lefebvre, Patrick

Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)

与结缔组织疾病 (CTD) 相关的肺动脉高压 (PAH) 患者的疾病经济负担

期刊:Pulmonary Circulation

影响因子:2.5

doi:10.1002/pul2.12218

Tsang, Yuen; Panjabi, Sumeet; Funtanilla, Vienica; Germack, Hayley D; Gauthier-Loiselle, Marjolaine; Manceur, Ameur M; Liu, Stephanie; Cloutier, Martin; Lefebvre, Patrick

Impact of the COVID-19 pandemic on care disruptions, outcomes, and costs in patients receiving pulmonary arterial hypertension-specific therapy in the United States of America: An observational study

COVID-19 大流行对美国接受肺动脉高压特异性治疗患者的护理中断、结果和成本的影响：一项观察性研究

期刊:Pulmonary Circulation

影响因子:2.5

doi:10.1002/pul2.12283

George, Marjorie Patricia; Germack, Hayley D; Goyal, Amit; Ward, Charlotte; Studer, Sean; Panjabi, Sumeet

Location of Care Delivery for Pulmonary Arterial Hypertension in the United States

美国肺动脉高压治疗服务地点

Impact of treatment escalation on rehospitalization among patients with pulmonary arterial hypertension

治疗升级对肺动脉高压患者再入院的影响

Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015-2019)

接受吸入三联疗法治疗的慢性阻塞性肺疾病急性加重患者的特征和结局：美国 SIRIUS I 队列研究结果（2015-2019 年）

Variation in Prevalence and Burden of Chronic Obstructive Pulmonary Disease by State and Insurance Type in the United States

美国各州和不同保险类型慢性阻塞性肺疾病患病率和疾病负担的差异

Factors associated with discontinuation of treatment for pulmonary arterial hypertension in the United States

美国肺动脉高压治疗中断的相关因素

Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)

肺动脉高压（PAH）患者延迟诊断的经济负担

US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies

美国商业健康保险计划在肺动脉高压治疗方面的覆盖动态

Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis

美国结缔组织疾病相关肺动脉高压患者的真实世界治疗模式：一项基于索赔数据的回顾性分析

Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD)

与结缔组织疾病 (CTD) 相关的肺动脉高压 (PAH) 患者的疾病经济负担

Impact of the COVID-19 pandemic on care disruptions, outcomes, and costs in patients receiving pulmonary arterial hypertension-specific therapy in the United States of America: An observational study

COVID-19 大流行对美国接受肺动脉高压特异性治疗患者的护理中断、结果和成本的影响：一项观察性研究